To determine the changes in gene expression that underpinned the recovery in Akt signaling, we compared gene expression profiles of MFE-296 endometrial cancer cells, resistant to two distinct FGFR inhibitors, with that of parental cells. This evidence concerns the gene AKT1 and endometrial cancer.